Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 34945 | 104 | 41.4 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
| 29 | 3 | HIV//VIROLOGY//HIV 1 | 108954 |
| 10 | 2 | AIDS RESEARCH AND HUMAN RETROVIRUSES//VIROLOGY//HIV 1 | 39664 |
| 34945 | 1 | HGP 30//MATRIX PROTEIN P17//HIV 1 MATRIX PROTEIN P17 | 104 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | HGP 30 | authKW | 1174447 | 4% | 100% | 4 |
| 2 | MATRIX PROTEIN P17 | authKW | 782962 | 4% | 67% | 4 |
| 3 | HIV 1 MATRIX PROTEIN P17 | authKW | 660625 | 3% | 75% | 3 |
| 4 | HIVP17 | authKW | 587223 | 2% | 100% | 2 |
| 5 | P17 | authKW | 481812 | 8% | 21% | 8 |
| 6 | ACCINATION | authKW | 293612 | 1% | 100% | 1 |
| 7 | ACRYLAMIDE IMMUNIZATION | authKW | 293612 | 1% | 100% | 1 |
| 8 | AIDS SURVEILLANCE | address | 293612 | 1% | 100% | 1 |
| 9 | AKT MEDIATED ERK PATHWAY | authKW | 293612 | 1% | 100% | 1 |
| 10 | ANGIOGIENESIS | authKW | 293612 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Immunology | 1094 | 49% | 0% | 51 |
| 2 | Virology | 863 | 22% | 0% | 23 |
| 3 | Infectious Diseases | 195 | 13% | 0% | 14 |
| 4 | Medicine, Research & Experimental | 137 | 14% | 0% | 15 |
| 5 | Biochemical Research Methods | 109 | 12% | 0% | 12 |
| 6 | Microbiology | 76 | 13% | 0% | 13 |
| 7 | Biotechnology & Applied Microbiology | 74 | 13% | 0% | 13 |
| 8 | Multidisciplinary Sciences | 25 | 3% | 0% | 3 |
| 9 | Pharmacology & Pharmacy | 15 | 10% | 0% | 10 |
| 10 | Biochemistry & Molecular Biology | 9 | 13% | 0% | 13 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | AIDS SURVEILLANCE | 293612 | 1% | 100% | 1 |
| 2 | EXPTL PL MED | 293612 | 1% | 100% | 1 |
| 3 | VACCINOL PL MICOBIOL | 293612 | 1% | 100% | 1 |
| 4 | VIENNA VA | 293612 | 1% | 100% | 1 |
| 5 | SECT EXPT ONCOL IMMUNOL | 167775 | 2% | 29% | 2 |
| 6 | DIPARTIMENTO MED CLIN SCI BIOCHIM | 146805 | 1% | 50% | 1 |
| 7 | EXPT PL MED | 119335 | 10% | 4% | 10 |
| 8 | SECT ANAT PATHOL HISTOL | 117441 | 2% | 20% | 2 |
| 9 | SEC PATHOL | 97869 | 1% | 33% | 1 |
| 10 | ANIM MODELS RETROVIRAL VACCINE SECT | 78293 | 2% | 13% | 2 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | HYBRIDOMA | 11323 | 9% | 0% | 9 |
| 2 | NEW MICROBIOLOGICA | 3818 | 3% | 0% | 3 |
| 3 | VACCINE | 1311 | 9% | 0% | 9 |
| 4 | VIRAL IMMUNOLOGY | 1025 | 2% | 0% | 2 |
| 5 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 874 | 4% | 0% | 4 |
| 6 | PATHOGENS AND DISEASE | 664 | 1% | 0% | 1 |
| 7 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 577 | 2% | 0% | 2 |
| 8 | HIV CLINICAL TRIALS | 570 | 1% | 0% | 1 |
| 9 | HUMAN VACCINES | 555 | 1% | 0% | 1 |
| 10 | AIDS | 541 | 4% | 0% | 4 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | HGP 30 | 1174447 | 4% | 100% | 4 | Search HGP+30 | Search HGP+30 |
| 2 | MATRIX PROTEIN P17 | 782962 | 4% | 67% | 4 | Search MATRIX+PROTEIN+P17 | Search MATRIX+PROTEIN+P17 |
| 3 | HIV 1 MATRIX PROTEIN P17 | 660625 | 3% | 75% | 3 | Search HIV+1+MATRIX+PROTEIN+P17 | Search HIV+1+MATRIX+PROTEIN+P17 |
| 4 | HIVP17 | 587223 | 2% | 100% | 2 | Search HIVP17 | Search HIVP17 |
| 5 | P17 | 481812 | 8% | 21% | 8 | Search P17 | Search P17 |
| 6 | ACCINATION | 293612 | 1% | 100% | 1 | Search ACCINATION | Search ACCINATION |
| 7 | ACRYLAMIDE IMMUNIZATION | 293612 | 1% | 100% | 1 | Search ACRYLAMIDE+IMMUNIZATION | Search ACRYLAMIDE+IMMUNIZATION |
| 8 | AKT MEDIATED ERK PATHWAY | 293612 | 1% | 100% | 1 | Search AKT+MEDIATED+ERK+PATHWAY | Search AKT+MEDIATED+ERK+PATHWAY |
| 9 | ANGIOGIENESIS | 293612 | 1% | 100% | 1 | Search ANGIOGIENESIS | Search ANGIOGIENESIS |
| 10 | ANTIGEN CAPTURE EIA | 293612 | 1% | 100% | 1 | Search ANTIGEN+CAPTURE+EIA | Search ANTIGEN+CAPTURE+EIA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | IARIA, ML , FIORENTINI, S , FOCA, E , ZICARI, S , GIAGULLI, C , CACCURI, F , FRANCISCI, D , DI PERRI, G , CASTELLI, F , BALDELLI, F , ET AL (2014) SYNTHETIC HIV-1 MATRIX PROTEIN P17-BASED AT20-KLH THERAPEUTIC IMMUNIZATION IN HIV-1-INFECTED PATIENTS RECEIVING ANTIRETROVIRAL TREATMENT: A PHASE I SAFETY AND IMMUNOGENICITY STUDY.VACCINE. VOL. 32. ISSUE 9. P. 1072-1078 | 17 | 63% | 3 |
| 2 | CACCURI, F , MARSICO, S , FIORENTINI, S , CARUSO, A , GIAGULLI, C , (2016) HIV-1 MATRIX PROTEIN P17 AND ITS RECEPTORS.CURRENT DRUG TARGETS. VOL. 17. ISSUE 1. P. 23 -32 | 24 | 26% | 1 |
| 3 | FOCA, E , IARIA, ML , CACCURI, F , FIORENTINI, S , MOTTA, D , GIAGULLI, C , CASTELLI, F , CARUSO, A , (2015) LONG-LASTING HUMORAL IMMUNE RESPONSE INDUCED IN HIV-1-INFECTED PATIENTS BY A SYNTHETIC PEPTIDE (AT20) DERIVED FROM THE HIV-1 MATRIX PROTEIN P17 FUNCTIONAL EPITOPE.HIV CLINICAL TRIALS. VOL. 16. ISSUE 4. P. 157 -162 | 10 | 56% | 0 |
| 4 | OTA, A , UEDA, S , (1999) ANALYSIS OF THE ANTI-HIV-1 ACTIVITY OF AN ANTI-P17-DERIVATIVE PEPTIDE (P30-52) MONOCLONAL ANTIBODY.HYBRIDOMA. VOL. 18. ISSUE 4. P. 305-314 | 12 | 71% | 1 |
| 5 | CACCURI, F , IARIA, ML , CAMPILONGO, F , VARNEY, K , ROSSI, A , MITOLA, S , SCHIAREA, S , BUGATTI, A , MAZZUCA, P , GIAGULLI, C , ET AL (2016) CELLULAR ASPARTYL PROTEASES PROMOTE THE UNCONVENTIONAL SECRETION OF BIOLOGICALLY ACTIVE HIV-1 MATRIX PROTEIN P17.SCIENTIFIC REPORTS. VOL. 6. ISSUE . P. - | 18 | 27% | 0 |
| 6 | CACCURI, F , RUECKERT, C , GIAGULLI, C , SCHULZE, K , BASTA, D , ZICARI, S , MARSICO, S , CERVI, E , FIORENTINI, S , SLEVIN, M , ET AL (2014) HIV-1 MATRIX PROTEIN P17 PROMOTES LYMPHANGIOGENESIS AND ACTIVATES THE ENDOTHELIN-1/ENDOTHELIN B RECEPTOR AXIS.ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. VOL. 34. ISSUE 4. P. 846-856 | 13 | 28% | 4 |
| 7 | GIOMBINI, E , DOLCETTI, R , CACCURI, F , SELLERI, M , ROZERA, G , ABBATE, I , BARTOLINI, B , MARTORELLI, D , FAE, DA , FIORENTINI, S , ET AL (2014) DETECTION OF HIV-1 MATRIX PROTEIN P17 QUASISPECIES VARIANTS IN PLASMA OF CHRONIC HIV-1-INFECTED PATIENTS BY ULTRA-DEEP PYROSEQUENCING.JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. VOL. 66. ISSUE 3. P. 332-339 | 13 | 27% | 1 |
| 8 | FIORENTINI, S , MARSICO, S , BECKER, PD , IARIA, ML , BRUNO, R , GUZMAN, CA , CARUSO, A , (2008) SYNTHETIC PEPTIDE AT20 COUPLED TO KLH ELICITS ANTIBODIES AGAINST A CONSERVED CONFORMATIONAL EPITOPE FROM A MAJOR FUNCTIONAL AREA OF THE HIV-1 MATRIX PROTEIN P17.VACCINE. VOL. 26. ISSUE 36. P. 4758-4765 | 12 | 32% | 6 |
| 9 | BUGATTI, A , GIAGULLI, C , URBINATI, C , CACCURI, F , CHIODELLI, P , ORESTE, P , FIORENTINI, S , ORRO, A , MILANESI, L , D'URSI, P , ET AL (2013) MOLECULAR INTERACTION STUDIES OF HIV-1 MATRIX PROTEIN P17 AND HEPARIN IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF P17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 288. ISSUE 2. P. 1150 -1161 | 13 | 21% | 4 |
| 10 | CACCURI, F , GIAGULLI, C , REICHELT, J , MARTORELLI, D , MARSICO, S , BUGATTI, A , BARONE, I , RUSNATI, M , GUZMAN, CA , DOLCETTI, R , ET AL (2014) SIMIAN IMMUNODEFICIENCY VIRUS AND HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 MATRIX PROTEINS SPECIFY DIFFERENT CAPABILITIES TO MODULATE B CELL GROWTH.JOURNAL OF VIROLOGY. VOL. 88. ISSUE 10. P. 5706-5717 | 12 | 20% | 3 |
Classes with closest relation at Level 1 |